Why did Seelos Therapeutics Inc. (SEEL) stock price plunge in premarket?
Seelos Therapeutics, Inc. (SEEL), a clinical-stage biopharmaceutical company specializing to develop technologies and therapeutics for the treatment of central nervous system and respiratory disorders, declared the commencement of an underwritten public offering of shares of common stock. At last check, shares of Seelos Therapeutics Inc. (SEEL) were down -7.34% at $3.03. SEEL’s stock closed the […]
